The Latest Headlines at American Banking and Market News
Ryan Specialty Holdings, Inc. (NYSE:RYAN) Receives Consensus Rating of “Hold” from Analysts
Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) have received a consensus recommendation of “Hold” from the nine analysts that are presently covering the stock, MarketBeat.com reports. One investment... More of this article »
Cabot Co. (NYSE:CBT) Receives Consensus Rating of “Hold” from Analysts
Shares of Cabot Co. (NYSE:CBT – Get Free Report) have earned a consensus rating of “Hold” from the five analysts that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated... More of this article »
Contrasting Atmus Filtration Technologies (ATMU) and Its Competitors
Atmus Filtration Technologies (NYSE:ATMU – Get Free Report) is one of 74 publicly-traded companies in the “Motor vehicle parts & accessories” industry, but how does it weigh in compared to its rivals? We will... More of this article »
HC Wainwright Analysts Decrease Earnings Estimates for Ocular Therapeutix, Inc. (NASDAQ:OCUL)
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) – Research analysts at HC Wainwright lowered their Q2 2024 earnings estimates for shares of Ocular Therapeutix in a report released on Wednesday, May 8th. HC Wainwright... More of this article »
Q2 2024 EPS Estimates for Nucor Co. (NYSE:NUE) Reduced by Analyst
Nucor Co. (NYSE:NUE – Free Report) – Analysts at Zacks Research reduced their Q2 2024 earnings estimates for shares of Nucor in a research note issued to investors on Thursday, May 9th. Zacks Research analyst M. Agrawal... More of this article »
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have received an average recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the company, Marketbeat.com... More of this article »
Zacks Research Brokers Lift Earnings Estimates for Newmont Co. (NYSE:NEM)
Newmont Co. (NYSE:NEM – Free Report) – Investment analysts at Zacks Research increased their Q2 2024 EPS estimates for Newmont in a research note issued to investors on Thursday, May 9th. Zacks Research analyst A. Barman... More of this article »
Lifesci Capital Weighs in on Olema Pharmaceuticals, Inc.’s Q2 2024 Earnings (NASDAQ:OLMA)
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – Equities researchers at Lifesci Capital issued their Q2 2024 earnings per share (EPS) estimates for shares of Olema Pharmaceuticals in a note issued to investors... More of this article »
Sidoti Csr Brokers Boost Earnings Estimates for The ODP Co. (NASDAQ:ODP)
The ODP Co. (NASDAQ:ODP – Free Report) – Equities researchers at Sidoti Csr upped their Q2 2024 EPS estimates for ODP in a research report issued on Thursday, May 9th. Sidoti Csr analyst G. Burns now anticipates that... More of this article »
Q2 2024 Earnings Forecast for Osisko Gold Royalties Ltd (NYSE:OR) Issued By National Bank Financial
Osisko Gold Royalties Ltd (NYSE:OR – Free Report) – Analysts at National Bank Financial raised their Q2 2024 EPS estimates for shares of Osisko Gold Royalties in a research report issued to clients and investors on ... More of this article »
Essential Properties Realty Trust, Inc. (NYSE:EPRT) Receives Average Recommendation of “Buy” from Analysts
Essential Properties Realty Trust, Inc. (NYSE:EPRT – Get Free Report) has been assigned an average recommendation of “Buy” from the nine brokerages that are presently covering the company, Marketbeat reports. Nine... More of this article »
NexGen Energy Ltd. to Post Q2 2024 Earnings of ($0.03) Per Share, Raymond James Forecasts (NYSE:NXE)
NexGen Energy Ltd. (NYSE:NXE – Free Report) – Equities research analysts at Raymond James decreased their Q2 2024 earnings per share estimates for shares of NexGen Energy in a note issued to investors on Wednesday,... More of this article »
HC Wainwright Equities Analysts Lift Earnings Estimates for Nuvectis Pharma, Inc. (NASDAQ:NVCT)
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) – Equities researchers at HC Wainwright lifted their Q2 2024 earnings estimates for Nuvectis Pharma in a research report issued on Wednesday, May 8th. HC Wainwright... More of this article »